Quadcap Wealth Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$418K Sell
1,864
-16
-0.9% -$3.99K 0.05% 280
2025
Q4
$453K Buy
1,880
+3
+0.2% +$767 0.05% 279
2025
Q3
$514K Sell
1,877
-3
-0.2% -$819 0.06% 265
2025
Q2
$485K Buy
1,880
+45
+2% +$10.7K 0.06% 260
2025
Q1
$411K Buy
1,835
+60
+3% +$14K 0.06% 269
2024
Q4
$406K Buy
+1,775
New +$427K 0.06% 272

Other funds holding RMD

Quadcap Wealth Management's RMD Position: Q1 2026 in Review

Quadcap Wealth Management reduced its ResMed (RMD) stake by 0.85% in Q1 2026, selling an estimated $3.99K and leaving 1,864 shares worth $418K. The position accounts for 0.05% of the portfolio, ranked #280.

Quadcap Wealth Management first reported a position in RMD in Q4 2024 and has held it in 6 quarters since. The position peaked at $514K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Quadcap Wealth Management held 1,864 shares of ResMed worth $418K as of Q1 2026.
  • Quadcap Wealth Management sold 16 ResMed shares in Q1 2026, an estimated $3.99K.
  • ResMed made up 0.05% of Quadcap Wealth Management's portfolio in Q1 2026, its #280 holding.
  • Quadcap Wealth Management first reported a position in ResMed in Q4 2024 and has held it in 6 quarters since.
  • Quadcap Wealth Management's ResMed position peaked at $514K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Quadcap Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.